Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A123260-1g | 1g | In stock | $90.90 | |
A123260-5g | 5g | In stock | $286.90 | |
A123260-10g | 10g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $516.90 | |
A123260-25g | 25g | In stock | $1,162.90 | |
A123260-100g | 100g | In stock | $4,184.90 |
Potent, long-acting L-type calcium channel blocker
Synonyms | amlodipine|88150-42-9|Norvasc|Amlocard|Coroval|Lipinox|Amlodipino|Amlodipinum|Amlodipine Free Base|AMLODIPINE BASE|Caduet|Istin|Amlodipinum [Latin]|CHEBI:2668|3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-d |
---|---|
Specifications & Purity | 98% |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | ALLOSTERIC MODULATOR, GATING INHIBITOR |
Mechanism of action | Gating inhibitor of Ca v1.2;Gating inhibitor of Ca v1.3;Allosteric modulator of P2X4 |
Product Description | A dihydropyridine calcium channel blocker; activity resides mainly in the (-)-isomer. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488179669 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488179669 |
IUPAC Name | 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
INCHI | InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3 |
InChi Key | HTIQEAQVCYTUBX-UHFFFAOYSA-N |
Canonical SMILES | CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN |
Isomeric SMILES | CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN |
PubChem CID | 2162 |
Molecular Weight | 408.88 |
PubChem CID | 2162 |
---|---|
DrugBank Ligand | DB00381 |
Wikipedia | Amlodipine |
CAS Registry No. | 88150-42-9 |
ChEMBL Ligand | CHEMBL1491 |
PEP | amlodipine |
DrugCentral Ligand | 183 |
PubChem SID | 488179669 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
I2318165 | Certificate of Analysis | Sep 25, 2023 | A123260 |
H2309517 | Certificate of Analysis | Aug 17, 2023 | A123260 |
J1921140 | Certificate of Analysis | Aug 04, 2023 | A123260 |
C2302442 | Certificate of Analysis | Mar 15, 2023 | A123260 |
C2302447 | Certificate of Analysis | Mar 06, 2023 | A123260 |
C2302443 | Certificate of Analysis | Mar 06, 2023 | A123260 |
B2428140 | Certificate of Analysis | Jul 21, 2022 | A123260 |
H2217132 | Certificate of Analysis | Jul 21, 2022 | A123260 |
H2217133 | Certificate of Analysis | Jul 21, 2022 | A123260 |
H2217134 | Certificate of Analysis | Jul 21, 2022 | A123260 |
Solubility | Soluble in dimethyl sulfoxide, ethanol, water, dimethyl formamide, acetone, chloroform, ethyl acetate and methanol.Water solubility:75.3 mg/L |
---|---|
Melt Point(°C) | 178-179 ºC |
Pictogram(s) | GHS06, GHS08, GHS09, GHS05 |
---|---|
Signal | Danger |
Hazard Statements | H301:Toxic if swallowed H373:Causes damage to organs through prolonged or repeated exposure H318:Causes serious eye damage H400:Very toxic to aquatic life H410:Very toxic to aquatic life with long lasting effects |
Precautionary Statements | P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P270:Do not eat, drink or smoke when using this product. P391:Collect spillage. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P317:Get emergency medical help. P319:Get medical help if you feel unwell. |
1. Christopoulos A, Changeux JP, Catterall WA, Fabbro D, Burris TP, Cidlowski JA, Olsen RW, Peters JA, Neubig RR, Pin JP et al.. (2014) International union of basic and clinical pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands.. Pharmacol Rev, 66 (4): (918-47). [PMID:25026896] |